Büchau Amanda S, Schauber Jürgen, Hultsch Thomas, Stuetz Anton, Gallo Richard L
Division of Dermatology, Department of Medicine, University of California, San Diego and VA San Diego Healthcare System, San Diego, California, USA.
Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
J Invest Dermatol. 2008 Nov;128(11):2646-2654. doi: 10.1038/jid.2008.135. Epub 2008 May 22.
Calcineurin inhibitors are potent inhibitors of T-cell-receptor mediated activation of the adaptive immune system. The effects of this class of drug on the innate immune response system are not known. Keratinocytes are essential to innate immunity in skin and rely on toll-like receptors (TLRs) and antimicrobial peptides to appropriately recognize and respond to injury or microbes. In this study we examined the response of cultured human keratinocytes to pimecrolimus. We observed that pimecrolimus enhances distinct expression of cathelicidin, CD14, and human beta-defensin-2 and beta-defensin-3 in response to TLR2/6 ligands. Some of these responses were further enhanced by 1,25 vitamin D3. Pimecrolimus also increased the functional capacity of keratinocytes to inhibit growth of Staphylococcus aureus and decreased TLR2/6-induced expression of IL-10 and IL-1beta. Furthermore, pimecrolimus inhibited nuclear translocation of NFAT and NF-kappaB in keratinocytes. These observations uncover a previously unreported function for pimecrolimus in cutaneous innate host defense.
钙调神经磷酸酶抑制剂是T细胞受体介导的适应性免疫系统激活的强效抑制剂。这类药物对先天性免疫反应系统的影响尚不清楚。角质形成细胞对皮肤的先天性免疫至关重要,它们依靠Toll样受体(TLR)和抗菌肽来适当地识别并应对损伤或微生物。在本研究中,我们检测了培养的人角质形成细胞对吡美莫司的反应。我们观察到,吡美莫司可增强角质形成细胞在响应TLR2/6配体时cathelicidin、CD14、人β-防御素-2和β-防御素-3的特异性表达。其中一些反应会被1,25-维生素D3进一步增强。吡美莫司还提高了角质形成细胞抑制金黄色葡萄球菌生长的功能能力,并降低了TLR2/6诱导的IL-10和IL-1β表达。此外,吡美莫司抑制了角质形成细胞中NFAT和NF-κB的核转位。这些观察结果揭示了吡美莫司在皮肤先天性宿主防御中以前未报道的功能。